Cargando…
Psychiatric Symptoms and Quality of Life in Patients with Drug-Refractory Epilepsy Receiving Adjunctive Levetiracetam Therapy
BACKGROUND AND PURPOSE: Levetiracetam (LEV) is a new antiepileptic drug that has been found to be effective as an adjunctive therapy for uncontrolled partial seizures. However, the results of several studies suggested that LEV has negative psychotropic effects, including irritability, aggressiveness...
Autores principales: | Lee, Jang-Joon, Song, Hyun-Seok, Hwang, Yang-Ha, Lee, Ho-Won, Suh, Chung-Kyu, Park, Sung-Pa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212598/ https://www.ncbi.nlm.nih.gov/pubmed/22087206 http://dx.doi.org/10.3988/jcn.2011.7.3.128 |
Ejemplares similares
-
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
por: de MANREZA, Maria Luiza Giraldes, et al.
Publicado: (2021) -
Neuropsychological implications of adjunctive levetiracetam in childhood epilepsy
por: Posar, Annio, et al.
Publicado: (2014) -
Increased EEG Current-Source Density in the High Beta Frequency Band Induced by Levetiracetam Adjunctive Therapy in Refractory Partial Epilepsy
por: Park, Sung-Pa, et al.
Publicado: (2009) -
Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
por: Suh, Guk-Hee, et al.
Publicado: (2009) -
The efficacy and side effects of levetiracetam on refractory epilepsy in children
por: Incecik, Faruk, et al.
Publicado: (2012)